Drivers of peak sales for pharmaceutical brands

Publisher:
Springer
Publication Type:
Journal Article
Citation:
Quantitative Marketing and Economics, 2010, 8 (4), pp. 429 - 460
Issue Date:
2010-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2013003203OK.pdf360.02 kB
Adobe PDF
Peak sales are an important metric in the pharmaceutical industry. Specifically, managers are focused on the height-of-peak-sales and the time required achieving peak sales. We analyze how order of entry and quality affect the level of peak sales and the time-to-peak-sales of pharmaceutical brands. We develop a growth model that includes these two variables as well as control variables for own and competitive marketing activities. We find that early entrants achieve peak sales later, and they have higher peak-sales levels. High-quality brands achieve peak sales earlier, and their peak-sales levels are higher. In addition, quality has a moderating effect on the order of entry effect on time-to-peak-sales. Our results indicate that late entrants have longer expected time-to-peak-sales when they introduce a brand with high quality.
Please use this identifier to cite or link to this item: